AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care
NCT ID: NCT06683963
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
450 participants
INTERVENTIONAL
2024-12-31
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement
NCT03776357
AI-Assisted Rehabilitation In Frailty
NCT07176520
Effectiveness of a Wearable Device-based Assisted Post-stroke Rehabilitation System
NCT04997408
Feasibility of Unsupervised Therapy After Neurological or Orthopaedical Injury in the Home Setting With a Hand Rehabilitation Device (ReHandyBot) and an Assistive Smartphone Application (RehabCoach)
NCT07182734
Perceptions of RehAtt Mixed Reality System
NCT06641336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control - usual care
Business as usual in community hospital, no added device intervention
No interventions assigned to this group
Intervention - Rebee
Addition of Rebee device during and after community hospital stay
Rebee
Tablet device with accompanying sensor device. Tablet device is preloaded with exercises, to be taught to patients during their hospital stay, and to be continued post-discharge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rebee
Tablet device with accompanying sensor device. Tablet device is preloaded with exercises, to be taught to patients during their hospital stay, and to be continued post-discharge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 60 and above
3. Speak English/Mandarin
4. Able to follow instructions, no cognitive impairment
5. No MDRO (MultiDrug Resistant Organism)
6. Suitable and able to wear motion sensor on upper and lower limbs
7. Suitable and able to engage in Rebee exercises
Exclusion Criteria
2. Below 60 years old
3. Unable to speak English/Mandarin
4. Cognitive impaired, unable to follow instructions
5. Has MDRO
6. Not suitable to wear motion sensor on upper and lower limbs
7. Refusal to participate / give informed consent
60 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rebee Health
UNKNOWN
Jurong Community Hospital
UNKNOWN
SingHealth Community Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Low Lian Leng
A/Prof
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20242246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.